FDC Limited Reports Strong Q4 FY26 Results

FDC Limited revealed robust financial results for the fourth quarter and full fiscal year ending March 31, 2026. The company's standalone net profit surged by an impressive 122.05% to ₹107.07 crore, up from ₹48.22 crore in the same period last year. This profit boost was accompanied by a solid 17.09% rise in revenue from operations, reaching ₹564.36 crore compared to ₹482.00 crore a year ago.

Labor Code Impact

The company reported an exceptional item of ₹20.79 crore for the fiscal year. This charge accounts for estimated additional obligations stemming from the government's notification of new labor codes. While this impacted the annual profit, it is categorized as a one-time regulatory cost.

Investor Outlook

This strong performance highlights FDC's improved operational efficiency and effective sales strategies. Investors are closely monitoring how the company will manage the ongoing financial implications of the new labor codes on its cost structure in the coming quarters. FDC's primary focus remains on its core pharmaceutical business, which is expected to continue as a key growth driver.

Key Financials (Q4 FY26)

• Standalone Revenue: ₹564.36 crore (up 17.09% year-over-year)
• Standalone Net Profit: ₹107.07 crore (up 122.05% year-over-year)
• Consolidated Revenue: ₹584.79 crore
• Consolidated Net Profit: ₹103.40 crore

Full Year (FY26) Financials

• Consolidated Revenue: ₹2,170.03 crore
• Consolidated Net Profit: ₹281.42 crore
• Exceptional Item (Labour Codes): ₹20.79 crore

Risks and Future Tracking

Potential future impacts on employee benefit policies and associated costs are a key area to watch as Central and State Rules under the New Labour Codes are finalized. Investors and analysts will be tracking FDC's future commentary on expenses and profitability, as well as the performance of its pharmaceutical products in its key markets.